You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CD51 + CD61 antibody [23C6] (ab20143)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab20143? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab20143 has been referenced in 6 publications.

  1. Martino MM et al. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 30:1089-97 (2009). PubMed: 19027948
  2. Scarlett A et al. Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin alphaVbeta3. J Endocrinol 196:509-17 (2008). PubMed: 18310446
  3. Lalitkumar PG et al. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Hum Reprod 22:3031-7 (2007). PubMed: 17890724
  4. Zhou Z et al. Regulation of osteoclast function and bone mass by RAGE. J Exp Med 203:1067-80 (2006). PubMed: 16606672
  5. Marshall JF et al. Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J Cell Sci 108 ( Pt 3):1227-38 (1995). PubMed: 7542669
  6. Horton MA et al. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res 45:5663-9 (1985). PubMed: 4053038

Publishing research using ab20143? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"